Stocks to Watch: Aurobindo Pharma, Panacea Biotec, InterGlobe Aviation, CG Power Industrial, AvenuesAI Under Scrutiny on June 5
Stock Market Updates: Key Stocks to Watch in Today's Trade
The US stock market is set for a busy day with several key developments that will shape investor sentiment. Here's a rundown of the top stocks to watch in today's trade:
Aurobindo Pharma Receives US FDA Approval
Aurobindo Pharma has received final approval from the US FDA to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg. The product, which is bioequivalent and therapeutically equivalent to the reference listed drug Xeljanz Tablets of PF Prism CV, will be launched immediately. Tofacitinib Tablets are indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis.
Read also: Tech and Resource Investments Dominate at Sohn Montreal Conference
CG Power and Industrial Solutions Expands Manufacturing Capacity
CG Power and Industrial Solutions has commissioned its extra-high-voltage (EHV) switchgear manufacturing facility in Nashik, Maharashtra. This is in addition to the S3 Unit-I manufacturing facility at Ambad, Nashik, which manufactures EHV circuit breakers in the 33kV to 800kV range.
HDFC Mutual Fund Restricts Lump-Sum Subscriptions
HDFC Mutual Fund has temporarily restricted lump-sum subscriptions in its Gold ETF and Gold ETF Fund of Fund (FoF) due to prevailing economic and market conditions.
Read also: Wall Street Ends Higher, Dow Reaches New Closing High
InterGlobe Aviation Adjusts International Network
In view of traditionally softer demand in the upcoming quarter and an incredibly challenging cost environment, IndiGo has decided to make temporary adjustments to a limited segment of its international network. The company will suspend operations to Langkawi, Krabi, Ho Chi Minh City, Hong Kong, and Shanghai from July 1, as well as to Siem Reap from July 3, 2026, until September 30, 2026. IndiGo will resume bookings for all the impacted services starting October 1, 2026.
AvenuesAI Receives In-Principle Approval from UAE Central Bank
The Central Bank of the UAE has granted in-principle approval to Avenues World FZ LLC, a step-down subsidiary of AvenuesAI, for a Retail Payment Services – Category III Licence in accordance with the Retail Payment Services and Card Schemes Regulation.
Key Block Deals and Investments
| Company | Buyer | Seller | Number of Shares | Price |
|---|---|---|---|---|
| Billionbrains Garage Ventures | Goldman Sachs Bank Europe SE | Friale Fund IV LLC | 1.13 crore | Rs 185.5 per share |
| Go Digit Insurance | Aditya Birla Sun Life Mutual Fund | Peak XV Partners Growth Investments III | 21.66 lakh | Rs 65 crore |
| Go Digit Insurance | JPMorgan (Taiwan) Eastern Technology Fund | Peak XV Partners Growth Investments III | 11.66 lakh | Rs 35 crore |
| Inventurus Knowledge Solutions | Kedaara Capital Public Markets Fund I | Scott Hayworth | 2 lakh | Rs 1,654.9 per share |
| Panacea Biotec | OHM Investment Corporation | - | 3.14 lakh | Rs 493.07 per share |
Stocks in F&O Ban
The following stocks have been placed under the F&O ban by the exchanges:
- Amber Enterprises India
- Kaynes Technology India
Investor Takeaway
Monitor the stocks mentioned for potential price movements due to regulatory scrutiny.
More in Market
Tech and Resource Investments Dominate at Sohn Montreal Conference
Wall Street Ends Higher, Dow Reaches New Closing High
AI Not Yet Replacing Credit Hedge Fund Traders, Barclays Warns
